The mechanism of non-blocking inhibition of sodium channels revealed by conformation-selective photolabeling.

Our results identify riluzole as the prototype of this new class of sodium channel inhibitors. Drugs of this class are expected to selectively prevent hyperexcitability, while having minimal effect on cells firing at a normal rate from a normal resting potential.